Biohit Investor Relations Material
Latest events
H2 2024
12 Feb, 2025
H1 2024
7 Aug, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Biohit Oyj
Access all reports
Biohit Oyj is a Finland-based biotechnology company specializing in the development and production of diagnostic tests and laboratory instruments. The company’s product portfolio includes enzyme immunoassay tests, liquid handling devices, and solutions for the detection and monitoring of gastrointestinal diseases and conditions. The company is headquartered in Helsinki, Finland, and its shares are listed on the Nasdaq Helsinki.
Latest articles
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
Ticker symbol
BIOBV
Country
🇫🇮 Finland